When to start antiretroviral therapy in resource-limited settings (Q34974260)

5 August 2017

title

When to start antiretroviral therapy in resource-limited settings (English)

1 reference

cost-effectiveness analysis

5 August 2017

main subject

anti-retroviral agent

0 references

1 reference

1

1 reference

5 August 2017

3

Robin Wood

1 reference

5 August 2017

9

Milton C Weinstein

1 reference

5 August 2017

8

Xavier Anglaret

1 reference

5 August 2017

5

Kenneth A Freedberg

1 reference

5 August 2017

7

A David Paltiel

1 reference

5 August 2017

10

Elena Losina

1 reference

5 August 2017

Lindsey L Wolf

2

1 reference

5 August 2017

Mariam O Fofana

series ordinal

4

1 reference

5 August 2017

Neil A Martinson

series ordinal

6

1 reference

5 August 2017

CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators

series ordinal

11

1 reference

5 August 2017

language of work or name

English

0 references

publication date

20 July 2009

1 reference

Annals of Internal Medicine

5 August 2017

published in

1 reference

5 August 2017

volume

151

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

157-166

1 reference

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Scaling up antiretroviral therapy in South Africa: the impact of speed on survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

HIV drug resistance surveillance for prioritizing treatment in resource-limited settings

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

CD4+ count-guided interruption of antiretroviral treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Approaches to rationing antiretroviral treatment: ethical and equity implications.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

HIV update: emerging clinical evidence and a review of recommendations for the use of highly active antiretroviral therapy.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Clinical impact and cost-effectiveness of co-trimoxazole prophylaxis in patients with HIV/AIDS in Côte d'Ivoire: a trial-based analysis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Expanding access to antiretroviral therapy through the public sector--the challenge of retaining patients in long-term primary care.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

The cost effectiveness of combination antiretroviral therapy for HIV disease.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

CD4 Decline and Incidence of Opportunistic Infections in Cape Town, South Africa

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3092478

Effect of Highly Active Antiretroviral Therapy on Time to Acquired Immunodeficiency Syndrome or Death using Marginal Structural Models

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19620143

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7326/0003-4819-151-3-200908040-00138

1 reference

release_nc73a3x6e5fbrikgafs56ievvq

5 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nc73a3x6e5fbrikgafs56ievvq

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

3092478

1 reference

5 August 2017

1 reference